Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers March 20, 2019
Pharmacy Choice - News - Drug Delivery Systems - March 20, 2019

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 12 of 12     Go To Page:

3/14/19 - Contrast Media Injectors Market Expected to Behold a CAGR of 5.0% Through 2014 - 2020
Albany, NY 03/14/2019 Contrast media are used to enhance quality of medical imaging such as CT, MRI, PET/CT and ultrasound. Their value has long been recognized by radiologists and is well illustrated by their frequent use in radiology departments worldwide. Contrast media injectors are devices employed for injecting contrast media into the b
3/14/19 - Janssens UNIFI trial of Stelara meets primary endpoint [Syrian Arab News Agency]
Janssen Pharmaceutical has reported positive results from the Phase III UNIFI clinical trial of subcutaneous Stelara as a maintenance therapy in adults with moderate to severe ulcerative colitis. UNIFI was conducted to assess the safety and efficacy of the drugs induction and maintenance dosing in moderate to severe UC patients who had an inadequat
3/14/19 - Lipocine Announces Presentation Highlighting Therapeutic Potential of LPCN 1144 in NAFLD and NASH Selected for ENDO 2019
Lipocine Inc., a specialty pharmaceutical company, announced today that it has been selected to present LPCN 1144 clinical results as part of ENDO 2019. Lipocine Inc. is a specialty pharmaceutical company developing innovative pharmaceutical products for use in men's and women's health using its proprietary drug delivery technologies.
3/14/19 - Neos Therapeutics Reports Fourth Quarter and Year-End 2018 Financial Results
Neos Therapeutics, Inc., a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release products using its proprietary modified-release drug delivery and orally disintegrating tablet technology platforms, today reported financial results for the fourth quarter and full year ended December 31, 2018...
3/13/19 - Amneal Announces Launch of Rivastigmine Transdermal System
BRIDGEWATER- Amneal Pharmaceuticals, Inc., today announced that it has launched its generic version of Exelon Patch, 4.6 mg/24 hours, 9.5 mg/24 hours, and 13.3 mg/24 hours. Amneal Pharmaceuticals, Inc., headquartered in Bridgewater, NJ, is an integrated pharmaceutical company focused on developing, manufacturing and distributing generic, brand and
3/13/19 - Esperion Announces Publication of Bempedoic Acid Study 1 Results in The New England Journal of Medicine
Esperion announced that results from the 2,230 patient, 52- week, Phase 3 long-term safety study of bempedoic acid were published today in The New England Journal of Medicine. Bempedoic acid and the bempedoic acid/ ezetimibe combination tablet new drug applications have been submitted to the United States Food and Drug Administration, as well as
3/13/19 - FDA Accepts Ubrogepant NDA for Acute Migraine [Tehran Times (Iran)]
The US Food and Drug Administration has accepted the New Drug Application of ubrogepant as an oral therapy for the acute treatment of migraine. The NDA, if approved by the FDA in the fourth quarter of 2019, would make the Allergan drug the first oral calcitonin gene-related peptide receptor antagonist approved for acute migraine treatment.
3/13/19 - Global Nicotine Patch Market to Grow at a CAGR of Approx 7% During 2019-2023 -
The "Global Nicotine Patch Market 2019-2023" report has been added to' s offering. The nicotine patch market will register a CAGR of close to 7% by 2023.. Organized retail channel has grown globally with the establishment of supermarkets, pharmacy stores, drugstores, convenience stores, hypermarkets, and specialty stores.
3/13/19 - Laurus gets USFDA nod for drug that treats malaria, auto-immune disease [T-break Tech (Middle East)]
Hyderabad- based Laurus Labs Limited said announced on Monday that it has received a final approval from the US Food and Drug Administration for Hydroxychloroquine tablets 200 mg, which is used for treatment of certain types of Malaria. The drug is a therapeutic equivalent of Plaquenil tablets of Concordia Pharmaceuticals, Inc.. In another developm
3/13/19 - Nasal Drug Delivery Technology Market Witness Highest Growth Of USD 67.99 Billion By 2025: Grand View Research Inc.
According to a report published by Grand View Research, Inc., Rising awareness about nasal products is one of the major factors driving the Nasal Drug Delivery Technology Market. According to a report, Nasal Drug Delivery Technology Market Analysis Report By Therapeutic Application, By Dosage Form, By Container Type, And Segment Forecasts, 2019- 20
3/13/19 - PAVmed Announces PortIO? Breakthrough
PAVmed Inc., a highly differentiated, multiproduct medical device company, today announced that its PortIO? Intraosseous Infusion System, which consists of an implantable intraosseous vascular access device and insertion kit, was able to achieve a maintenance-free implant duration of over 60 days in pre-clinical animal testing. Former President
3/13/19 - The Global Infusion Pumps & Accessories Market size is expected to reach $9.6 billion by 2024, rising at a market growth of 5.5% CAGR during the forecast period
The Global Infusion Pumps& Accessories Market size is expected to reach $9.6 billion by 2024, rising at a market growth of 5.5% CAGR during the forecast period. Read the full report: Infusion pumps and accessories are a set of drugs delivering devices which are used to administer medications in a controlled,
Articles(s): 1 - 12 of 12     Go To Page:

© 2019 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
Pharmacy Spanish
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement